Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49
United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Francis Burrows
24 Sep 2026
Chief Scientific Officer
Sold after exercise
20,726
$10.83
$224.51K
Francis Burrows
18 Dec 2025
Chief Scientific Officer
Sold after exercise
23,726
$9.78
$231.93K
Faheem Hasnain
9 Dec 2025
Director
Sold after exercise
10,000
$10.98
$109.76K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 3
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 749,020
History held since 10 Mar 2015